RMTI (Rockwell Medical) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RMTI Rockwell Medical Inc RMTI
47 GF Score
Price $8.70
GF Value $7.84
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Rockwell Medical Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Rockwell Medical  (NAS:RMTI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Rockwell Medical Cyclically Adjusted PS Ratio Related Terms


Rockwell Medical Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Cyclically Adjusted PS Ratio Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.07 0.15 0.18 0.08

Rockwell Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.12 0.08 0.09 0.06

RMTI vs MRMD, INIS, RAPH: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Cyclically Adjusted PS Ratio falls into.


RMTI
47GF Score
Rockwell Medical Inc RMTI
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Rockwell Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Rockwell Medical's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.492/333.9520*333.9520
=4.492

Current CPI (Jun. 2026) = 333.9520.

Rockwell Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 27.816 241.428 38.476
201612 28.584 241.432 39.538
201703 31.668 243.801 43.378
201706 28.546 244.955 38.917
201709 31.388 246.819 42.469
201712 31.529 246.524 42.711
201803 32.061 249.554 42.904
201806 31.985 251.989 42.389
201809 35.758 252.439 47.304
201812 33.082 251.233 43.974
201903 29.975 254.202 39.379
201906 28.051 256.143 36.572
201909 26.566 256.759 34.553
201912 26.438 256.974 34.358
202003 25.833 258.115 33.423
202006 25.185 257.797 32.625
202009 23.406 260.280 30.031
202012 17.826 260.474 22.855
202103 18.186 264.877 22.929
202106 17.770 271.696 21.842
202109 18.733 274.310 22.806
202112 17.944 278.802 21.494
202203 18.871 287.504 21.920
202206 21.217 296.311 23.912
202209 17.753 296.808 19.975
202212 16.722 296.797 18.815
202303 10.712 301.836 11.852
202306 9.775 305.109 10.699
202309 8.637 307.789 9.371
202312 7.711 306.746 8.395
202403 7.732 312.332 8.267
202406 8.064 314.175 8.572
202409 8.734 315.301 9.251
202412 7.502 315.605 7.938
202503 5.545 319.799 5.790
202506 4.684 322.561 4.849
202509 4.421 324.800 4.546
202512 4.655 324.054 4.797
202603 4.398 330.213 4.448
202606 4.492 333.952 4.492

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Rockwell Medical (RMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of $8.70 is trading 11% above its estimated GF Value™ of $7.84. GuruFocus considers Rockwell Medical to be Modestly Overvalued.

Key valuation signals for RMTI:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $7.84 vs. price of $8.70 (11% above fair value)
  • GF Score™: 47/100 with 2 warning signs

No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rockwell Medical Business Description

Other Exchanges RWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
47GF Score

Get the complete analysis for RMTI

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.70
Price
$7.84
GF Value